GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daehan New Pharm Co Ltd (XKRX:054670) » Definitions » Shiller PE Ratio

Daehan New Pharm Co (XKRX:054670) Shiller PE Ratio : 23.79 (As of Jun. 22, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Daehan New Pharm Co Shiller PE Ratio?

As of today (2024-06-22), Daehan New Pharm Co's current share price is ₩7730.00. Daehan New Pharm Co's E10 for the quarter that ended in Mar. 2024 was ₩324.90. Daehan New Pharm Co's Shiller PE Ratio for today is 23.79.

The historical rank and industry rank for Daehan New Pharm Co's Shiller PE Ratio or its related term are showing as below:

XKRX:054670' s Shiller PE Ratio Range Over the Past 10 Years
Min: 24.19   Med: 47.71   Max: 9130.43
Current: 24.19

During the past years, Daehan New Pharm Co's highest Shiller PE Ratio was 9130.43. The lowest was 24.19. And the median was 47.71.

XKRX:054670's Shiller PE Ratio is ranked worse than
50.37% of 534 companies
in the Drug Manufacturers industry
Industry Median: 24.07 vs XKRX:054670: 24.19

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Daehan New Pharm Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩372.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₩324.90 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Daehan New Pharm Co Shiller PE Ratio Historical Data

The historical data trend for Daehan New Pharm Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daehan New Pharm Co Shiller PE Ratio Chart

Daehan New Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 46.72 30.68

Daehan New Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.65 35.97 29.72 30.68 25.61

Competitive Comparison of Daehan New Pharm Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Daehan New Pharm Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daehan New Pharm Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daehan New Pharm Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Daehan New Pharm Co's Shiller PE Ratio falls into.



Daehan New Pharm Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Daehan New Pharm Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=7730.00/324.9
=23.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daehan New Pharm Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Daehan New Pharm Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=372/118.8477*118.8477
=372.000

Current CPI (Mar. 2024) = 118.8477.

Daehan New Pharm Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 47.000 99.353 56.222
201409 98.000 99.608 116.929
201412 -17.000 99.098 -20.388
201503 90.600 99.720 107.978
201506 98.000 100.050 116.413
201509 93.000 100.110 110.407
201512 14.000 100.220 16.602
201603 95.000 100.560 112.277
201606 113.000 100.790 133.245
201609 56.000 101.460 65.597
201612 -669.000 101.560 -782.878
201703 120.000 102.850 138.665
201706 -1,244.000 102.610 -1,440.859
201709 162.000 103.490 186.040
201712 -505.000 102.990 -582.756
201803 208.000 104.100 237.467
201806 -485.000 104.130 -553.550
201809 316.000 105.650 355.474
201812 135.000 104.350 153.756
201903 226.000 104.490 257.054
201906 245.000 104.880 277.629
201909 223.000 105.200 251.930
201912 390.000 105.120 440.930
202003 258.000 105.540 290.532
202006 273.000 104.870 309.387
202009 -82.000 106.200 -91.766
202012 -1,170.000 105.765 -1,314.719
202103 283.000 107.357 313.290
202106 332.000 107.579 366.778
202109 365.000 108.759 398.857
202112 118.000 109.676 127.867
202203 827.000 111.806 879.087
202206 233.000 114.083 242.732
202209 422.000 114.831 436.760
202212 250.000 115.200 257.916
202303 315.000 116.550 321.211
202306 458.000 117.140 464.677
202309 355.000 119.111 354.215
202312 -234.000 118.848 -234.000
202403 372.000 118.848 372.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Daehan New Pharm Co  (XKRX:054670) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Daehan New Pharm Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Daehan New Pharm Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Daehan New Pharm Co (XKRX:054670) Business Description

Traded in Other Exchanges
N/A
Address
1062-4 Namhyeon-dong, Gwanak-gu, Seoul, KOR, 137-851
Daehan New Pharm Co Ltd is a South Korea based company operating in the pharmaceutical sector. It is engaged in producing pharmaceutical products, animal health and nutrition, and bio products. The pharmaceutical products are tertan tab, amloc tab, tarocin SR tab, NP star tab and others. The animal health and nutrition products are starvac, pigcoc for calves, ocean doctor, and others. The bio range of the products by the group are CELRENA serum-free, BMPro serum-free, BMPro-V serum-free, ALyS505NK-EX serum-free and others.

Daehan New Pharm Co (XKRX:054670) Headlines

No Headlines